Garnon Julien, Koch Guillaume, Caudrelier Jean, Boatta Emanuele, Rao Pramod, Nouri-Neuville Maud, Ramamurthy Nitin, Cazzato Roberto Luigi, Gangi Afshin
Department of Interventional Radiology, Nouvel Hôpital Civil, 1, place de l'hôpital, 67096, Strasbourg Cedex, France.
Laboratoires ICube, CNRS, Université de Strasbourg, 300, Bd Sebastien Brant, 67400, Illkirch-Graffenstaden, France.
Cardiovasc Intervent Radiol. 2019 Jan;42(1):137-144. doi: 10.1007/s00270-018-2105-y. Epub 2018 Nov 1.
To report a technique of percutaneous retrohepatic hydrodissection, highlighting its potential to physically separate liver tumours from the inferior vena cava (IVC) and the ostia of the hepatic veins (HV).
Between December 2017 and April 2018, hydrodissection of the retrohepatic IVC was performed in 5 patients (5 females; mean age 64.5 years) undergoing percutaneous ablation of 5 liver metastases (mean size: 3.6 cm) located adjacent to the IVC. Number of hydrodissection needles, volume of hydrodissection, separation of tumour/liver parenchyma from IVC/HV post-hydrodissection; technical success of ablation; and complications were tabulated.
Two to three 22G spinal needles were required per case for adequate dissection. Mean volume to obtain sufficient hydrodissection was 410 ml on average. Physical separation of the IVC and tumour/hepatic parenchyma was successful in all cases, by 9 mm on average (range 5-12 mm). It also leaded to physical separation of the ostia of the right and middle HV in all cases. There was no early or delayed complication, notably no venous thrombosis in the post-operative period. All lesions but one were completely ablated after one session at 3-month follow-up. The patient with residual tumour was successfully retreated.
Retrohepatic hydrodissection is a feasible technique to separate a tumour from the IVC and/or ostia of the HV. This could potentially limit the heat-sink effect/reduce the risk of thrombosis. Larger follow-up studies are required to assess efficacy on a long-term basis.
报告一种经皮肝后间隙水分离技术,强调其在物理上分离肝肿瘤与下腔静脉(IVC)及肝静脉(HV)开口的潜力。
2017年12月至2018年4月期间,对5例(均为女性;平均年龄64.5岁)接受经皮消融位于IVC旁的5个肝转移瘤(平均大小:3.6 cm)的患者进行肝后IVC水分离。记录水分离针数量、水分离量、水分离后肿瘤/肝实质与IVC/HV的分离情况;消融技术成功率;以及并发症情况并制成表格。
每例患者需要2至3根22G脊椎穿刺针进行充分分离。平均获得足够水分离的量平均为410 ml。所有病例中IVC与肿瘤/肝实质均成功实现物理分离,平均分离9 mm(范围5 - 12 mm)。所有病例中右HV和中HV开口也实现了物理分离。无早期或延迟并发症,尤其是术后无静脉血栓形成。3个月随访时,除1例病变外,其余所有病变经一次治疗后均完全消融。残留肿瘤的患者成功接受再次治疗。
肝后间隙水分离是一种将肿瘤与IVC和/或HV开口分离的可行技术。这可能会限制热沉效应/降低血栓形成风险。需要更大规模的随访研究来长期评估其疗效。